Life Sciences Tools and Services

MGI released FY2026 Q1 earnings on April 24 After-Market (BJT), actual revenue CNY 585.34 M (forecast CNY 779.51 M), actual EPS CNY -0.26 (forecast CNY 0.0362)

MGI to release FY2026 Q1 earnings on April 25 After-Market (BJT), forecast revenue CNY 779.51 M, EPS CNY 0.0362

MGI to release FY2025 earnings report on April 25 during market hours (BJT), forecast revenue CNY 2.937 B, EPS CNY -0.1864

MGI released FY2025 Q4 earnings on February 27 During-Market (BJT), actual revenue CNY 910.7 M (forecast CNY 1.129 B), actual EPS CNY -0.2509 (forecast CNY -0.0146)

MGI released FY2025 earnings on February 27 During-Market (BJT), actual revenue CNY 2.78 B (forecast CNY 2.937 B), actual EPS CNY -0.54 (forecast CNY -0.1864)

Huada's US Subsidiary Completes Partnership with SOPHiAGenetics for Tumor Detection

MGI released FY2025 Q3 earnings on October 23 During-Market (BJT), actual revenue CNY 755.2 M (forecast CNY 734.4 M), actual EPS CNY -0.0391 (forecast CNY -0.0738)

MGI released FY2025 9-month earnings on October 23 During-Market (BJT), actual revenue CNY 1.869 B, actual EPS CNY -0.2868

MGI to Release FY2025 Q3 Earnings on October 24 During-Market (BJT), Forecast Revenue CNY 734.4 M, EPS CNY -0.0738

MGI released FY2025 Semi-Annual Earnings on August 22 After-Market (BJT), Actual Revenue: CNY 1.128 B, Actual EPS: CNY -0.3384

MGI released FY2025 Q2 earnings on August 22 After-Market (BJT), actual revenue CNY 658.64 M (forecast CNY 808.6 M), actual EPS CNY 0.0723 (forecast CNY -0.1115)

MGI to Release FY2025 Semi-Annual Earnings on August 23, 2025 (BJT)

Chasing Light Biotech and BGI Maker Form Strategic Partnership

BGI-Shenzhen Releases PrimeGen System to Enhance Primer Design Efficiency

BGI Genomics Launches PrimeGen System

Shenzhen Huada Technology Applies for New Trademark Registration

Huada 智造 Announces a Decline in International Patent Applications

Huada 智造 GenSIRO-16 system receives medical device registration certificate

Huada Technology's Subsidiary Obtains Medical Device Registration Certificate

MGI Launches EF6 Series Wireless Ultrasound Diagnostic Instruments

688114

MGI Tech Co., Ltd. celebrates its 10th anniversary, marking a decade of innovation in life sciences. The company has developed tools that have transformed genomics into a scalable and accessible field, serving over 3,560 users globally. MGI's advancements include high-performance sequencing systems and automated laboratories, significantly reducing the cost of whole-genome sequencing. As it enters its second decade, MGI focuses on integrating AI and multi-omics technologies to enhance scientific discovery across medicine, agriculture, and environmental science.

prnewswire

03:52 ETMGI Tech Celebrates 10 Years of Innovation, Empowering 3,560 Users Across Six Continents

On March 3, 2026, in Shenzhen, China, MGI Tech Co., Ltd. revealed the acquisition of STOmics and CycloneSEQ, showcasing a pivotal moment for the company. MGI focuses on creating essential tools and technologies that foster progress in the life sciences field. This strategic move highlights MGI's commitment to growth and innovation.

Unusual Whales

MGI Tech acquires STOmics and CycloneSEQ to offer integrated omics solutions, boosting innovation in life sciences.

MGI Tech Co., Ltd. has announced the acquisition of STOmics and CycloneSEQ, enhancing its capabilities in life sciences. This acquisition supports MGI's "SEQALL+GLI+Omics" strategy, making it the only manufacturer offering integrated short-read, long-read, and spatial omics solutions. STOmics' Stereo-seq technology and CycloneSEQ's nanopore sequencing platforms will be combined with MGI's existing technologies to provide comprehensive sequencing toolkits. This move aims to improve customer service, operational efficiency, and long-term partnership value in the life sciences sector.

fidelity

MGI Tech Announces Acquisition of STOmics and CycloneSEQ to Deliver Integrated Long-Read, Short-Read and Spatial Omics Solutions

Complete Genomics has announced the launch of its DNBSEQ-T7+ high-throughput sequencing platform at the AGBT 2026 conference. This system is designed for large-scale genomic applications, offering high performance with the ability to generate 48 billion reads in 24 hours. Priced at $800,000, it provides a cost-effective solution for population genomics and clinical research, delivering high data quality and operational efficiency. The company is also hosting presentations at the conference to showcase the platform's capabilities and collaborative research efforts.

07:00 ETComplete Genomics Highlights DNBSEQ-T7+ at AGBT 2026, Expanding High-Throughput Sequencing Capability

300676

MGI has announced its decision to sell its entire stake in Complete Genomics to Swiss Rockets AG for approximately $50 million. Bloomberg posted on X, highlighting this strategic move as part of MGI's broader business realignment. The transaction is expected to enhance MGI's focus on its core operations while allowing Swiss Rockets AG to expand its portfolio in the genomics sector. The deal underscores the ongoing consolidation in the biotechnology industry, as companies seek to optimize their assets and strengthen their market positions.

CoinLive

BGI Genomics

MGI to Divest Complete Genomics to Swiss Rockets AG for $50 Million

BNGO

OMIC

MGI Tech, a Chinese gene-sequencing firm, is selling its US subsidiary, Complete Genomics, to Swiss Rockets for USD 50 million to mitigate geopolitical risks. The deal allows Complete Genomics to operate independently in the US while MGI retains rights to 205 patents. This move aims to comply with local regulations amid a challenging policy environment in the US. MGI's revenue from the US market was CNY 474 million (USD 68.6 million) from 2023 to 2025, contributing about 5.5% to its total revenue. MGI has faced losses since 2023 due to declining demand for test kits.

Yicai

Bionano Genomics

SPDR S&P Biotech

VanEck Biotech ETF

Singular Genomics

Invesco Biotechnology & Genome ETF

Chinese Gene Sequencing Firm MGI to Sell US Unit to Swiss Rockets Amid Geopolitical Risks

MGI Tech Sells Complete Genomics to Swiss Rockets for $50 Million

MGI Tech Sells Complete Genomics to Swiss Rockets for $50 Million

MGI(688114.SH)

03:52 ETMGI Tech Celebrates 10 Years of Innovation, Empowering 3,560 Users Across Six Continents

MGI Tech acquires STOmics and CycloneSEQ to offer integrated omics solutions, boosting innovation in life sciences.

MGI Tech Announces Acquisition of STOmics and CycloneSEQ to Deliver Integrated Long-Read, Short-Read and Spatial Omics Solutions

07:00 ETComplete Genomics Highlights DNBSEQ-T7+ at AGBT 2026, Expanding High-Throughput Sequencing Capability

MGI to Divest Complete Genomics to Swiss Rockets AG for $50 Million

Chinese Gene Sequencing Firm MGI to Sell US Unit to Swiss Rockets Amid Geopolitical Risks

MGI Tech Sells Complete Genomics to Swiss Rockets for $50 Million